DE2120426A1 - Varicellavaccine - Google Patents
VaricellavaccineInfo
- Publication number
- DE2120426A1 DE2120426A1 DE19712120426 DE2120426A DE2120426A1 DE 2120426 A1 DE2120426 A1 DE 2120426A1 DE 19712120426 DE19712120426 DE 19712120426 DE 2120426 A DE2120426 A DE 2120426A DE 2120426 A1 DE2120426 A1 DE 2120426A1
- Authority
- DE
- Germany
- Prior art keywords
- virus
- varicella
- vaccine
- tissue culture
- humans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/25—Varicella-zoster virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3276970A | 1970-04-28 | 1970-04-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE2120426A1 true DE2120426A1 (de) | 1971-11-11 |
Family
ID=21866708
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19712120426 Pending DE2120426A1 (de) | 1970-04-28 | 1971-04-26 | Varicellavaccine |
Country Status (11)
Country | Link |
---|---|
AT (1) | AT303965B (xx) |
AU (1) | AU2788871A (xx) |
BE (1) | BE766333A (xx) |
DE (1) | DE2120426A1 (xx) |
ES (1) | ES390603A1 (xx) |
FR (1) | FR2092100B1 (xx) |
GB (1) | GB1293310A (xx) |
HU (1) | HU163131B (xx) |
IL (1) | IL36649A0 (xx) |
NL (1) | NL7103524A (xx) |
ZA (1) | ZA712711B (xx) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0043847A1 (en) * | 1980-01-25 | 1982-01-20 | The Wistar Institute Of Anatomy And Biology | Highly attenuated varicella virus vaccine and production thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2952825B1 (fr) | 2009-11-24 | 2012-05-25 | Goaster Jacqueline Le | Utilisation d'un vaccin contre le virus vzv/hsv3 pour traiter les infections herpetiques par le virus hsv1 et/ou le virus hsv2 |
-
1971
- 1971-03-16 NL NL7103524A patent/NL7103524A/xx unknown
- 1971-04-19 IL IL36649A patent/IL36649A0/xx unknown
- 1971-04-20 AU AU27888/71A patent/AU2788871A/en not_active Expired
- 1971-04-23 AT AT354771A patent/AT303965B/de not_active IP Right Cessation
- 1971-04-26 ES ES390603A patent/ES390603A1/es not_active Expired
- 1971-04-26 GB GB01385/71A patent/GB1293310A/en not_active Expired
- 1971-04-26 DE DE19712120426 patent/DE2120426A1/de active Pending
- 1971-04-27 ZA ZA712711A patent/ZA712711B/xx unknown
- 1971-04-27 FR FR7114922A patent/FR2092100B1/fr not_active Expired
- 1971-04-27 BE BE766333A patent/BE766333A/xx unknown
- 1971-04-27 HU HUME1354A patent/HU163131B/hu unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0043847A1 (en) * | 1980-01-25 | 1982-01-20 | The Wistar Institute Of Anatomy And Biology | Highly attenuated varicella virus vaccine and production thereof |
EP0043847A4 (en) * | 1980-01-25 | 1982-07-06 | Wistar Inst | HIGHLY ATTENUED CHICKENPOX VIRUS VACCINE AND PRODUCTION THEREOF. |
Also Published As
Publication number | Publication date |
---|---|
ES390603A1 (es) | 1974-04-01 |
IL36649A0 (en) | 1971-06-23 |
HU163131B (xx) | 1973-06-28 |
ZA712711B (en) | 1972-12-27 |
FR2092100B1 (xx) | 1974-08-30 |
AT303965B (de) | 1972-12-27 |
BE766333A (fr) | 1971-10-27 |
GB1293310A (en) | 1972-10-18 |
NL7103524A (xx) | 1971-11-01 |
AU2788871A (en) | 1972-10-26 |
FR2092100A1 (xx) | 1972-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69215355T2 (de) | Stabilisierter Varizella-Lebendimpfstoff | |
DE3911442A1 (de) | Impfstoff-praeparation | |
DE2516274C2 (de) | Verfahren zum Herstellen eines abgeschwächten Zytomegalie-Virus-Impfstoffes | |
DE2708668A1 (de) | Nd-impfstoff und verfahren zu seiner herstellung | |
EP0173241A2 (de) | Vakzine zur Behandlung der Harnwegsinfektionen | |
DE2423129C2 (de) | Temperaturempfindliche, nicht-pathogene Rinder-Adeno-Virus-Mutantenstämme, Verfahren zu ihrer Herstellung und diese Virusstämme enthaltender Lebendimpfstoff | |
DE2817891A1 (de) | Nd-impfstoff und verfahren zu seiner herstellung | |
DE2553998C2 (de) | Mumpsvaccin und Verfahren zu seiner Herstellung | |
DE2362067C2 (de) | Temperaturempfindliche, nicht-pathogene, infektiöse Rinder-Rhinotracheitis-Virusstämme, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Lebendimpfstoffen | |
DE2323847C3 (de) | Lebendimpfstoff zur Immunisierung von Rindern gegen die Parainfluenza-3-Virus-Infektion | |
CH414061A (de) | Verfahren zur Herstellung eines Impfstoffes gegen Masern | |
DE2655691C2 (de) | Temperaturempfindliche, vermehrungsfähige, nicht pathogene Varicella-Zoster-Viren, Verfahren zu ihrer Herstellung und diese Viren enthaltende Lebendvaccine | |
DE69306934T2 (de) | Geflügelkrankheit verursachende neue bakterie und daraus stammender impfstoff | |
DE2120426A1 (de) | Varicellavaccine | |
DE4104728C2 (de) | Verwendung eines Bakterien-Lysats zur Behandlung der atopischen Dermatitis | |
CH616959A5 (xx) | ||
DE3034238A1 (de) | Impfstoff zur bekaempfung der newcastle-krankheit und verfahren zur herstellung derselben | |
Jawetz et al. | Studies on herpes simplex virus: VII. Immunological comparison of strains of herpes simplex | |
DE2805311A1 (de) | Respiratorische synzytial-vakzine | |
DE1265916B (de) | Verfahren zur Herstellung eines Brucellose-Impfstoffs | |
DE3740182C2 (de) | Verfahren zur Herstellung eines Mutantenstamms von Bordetella bronchiseptica, der für einen Impfstoff für den Schutz von B. bronchiseptica-Infektionen nützlich ist, und daraus hergestellter AR-Impfstoff | |
DE2415353A1 (de) | Verfahren zur herstellung von temperaturempfindlichen, nicht pathogenen mutanten von herpes simplex typ 2-viren und ihre verwendung zur herstellung von vaccinen | |
DE2921829C2 (xx) | ||
DE1966436C3 (de) | Verwendung einer Antigen-Immunserum-Kombination als Impfstoff | |
DE2225548B2 (de) | Intravenös verträglicher Impfstoff gegen Staupe- und Hepatits contagiosa canis |